ERBB2 and metastatic neoplasm: This observation suggests that either CTCs represent a separate population of cells distinct from that which makes up the bulk of the metastatic disease, or that the cancer developed HER2 amplification in the interval between the patients’ metastatic biopsy and the CTC collection.